The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines

Journal of Affective Disorders

Volumn 217, Issue , 2017, Pages 266-280

  Malhi, Gin S ^a,b,c   Gessler, Danielle ^a,b,c   Outhred, Tim ^a,b,c  

^a St George Hospital and Community Health Service   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bipolar disorder; Clinical guidance; Depression; Lithium; Mania; Recommendations

Indexed keywords

LITHIUM; ANTIDEPRESSANT AGENT;

ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR II DISORDER; CYCLING; DRUG BLOOD LEVEL; DRUG MONITORING; ENDOCRINE FUNCTION; JUVENILE; KIDNEY FUNCTION; LITHIUM BLOOD LEVEL; MAINTENANCE THERAPY; MANIA; NEUROPROTECTION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SUICIDE; AGED; CONSENSUS; HUMAN;

AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CONSENSUS; HUMANS; LITHIUM; PRACTICE GUIDELINES AS TOPIC;

EID: 85018498332     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.03.052     Document Type: Article

References (38)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 2013, American Psychiatric Association, Washington, DC.
2. Bai, Y.-M., Chang, C.-J., Tsai, S.-Y., Chen, Y.-C., Hsiao, M.-C., Li, C.-T., Tu, P., Chang, S.-W., Shen, W.W., Su, T.-P., Taiwan consensus of pharmacological treatment for bipolar disorder. J. Chin. Med. Assoc. 76:10 (2013), 547–556.
3. BALANCE Investigators, Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (balance): a randomised open-label trial. Lancet 375:9712 (2010), 385–395.
4. Bauer, M., Gitlin, M., Essential Guide to Lithium Treatment. 2016, Springer, Switzerland.
5. Berk, M., Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int. J. Neuropsychopharmacol. 12:4 (2009), 441–445.
6. Berk, M., Kapczinski, F., Andreazza, A., Dean, O., Giorlando, F., Maes, M., Yücel, M., Gama, C., Dodd, S., Dean, B., Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35:3 (2011), 804–817.
7. Cade, J.F., Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 2 (1949), 349–352.
8. Cipriani, A., Hawton, K., Stockton, S., Geddes, J.R., Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ: Br. Med. J., 346, 2013.
9. Emsley, R., Flisher, A., Grobler, G., Seedat, S., Szabo, C., The South African Society of Psychiatrists (SASOP) treatment guidlelines for psychiatric disorders. South Afr. J. Psychiatry, 19(3), 2013, 2.
10. Frank, E., Nimgaonkar, V.L., Phillips, M.L., Kupfer, D.J., All the world'sa (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol. Psychiatry 20:1 (2015), 23–31.
11. Gershon, S., Chengappa, K.R., Malhi, G.S., Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disord. 11:s2 (2009), 34–44.
12. Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, J., Grunze, H., 2016. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J. Psychopharmacol., vol. 30(6), pp. 495–553.
13. Grof, P., Sixty years of lithium responders. Neuropsychobiology 62:1 (2010), 8–16.
14. Grunze, H., Vieta, E., Goodwin, G.M., Bowden, C., Licht, R.W., Moller, H.J., Kasper, S., Disorders, W.T.F. o.T.G. f.B., The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J. Biol. Psychiatry 14:3 (2013), 154–219.
15. Hirschfeld, R., Bowden, C.L., Gitlin, M.J., Keck, P.E., Suppes, T., Thase, M.E., Perlis, R.H., 2002. Practice Guideline for the Treatment of Patients with Bipolar Disorder.
16. Jeong, J.-H., Lee, J.G., Kim, M.-D., Sohn, I., Shim, S.-H., Wang, H.R., Woo, Y.S., Jon, D.-I., Seo, J.S., Shin, Y.-C., Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines. Neuropsychiatr. Dis. Treat., 11, 2015, 1561.
17. Jones, H., Geddes, J., Cipriani, A., 2017. Lithium and suicide prevention. In: The Science and Practice of Lithium Therapy, Springer, pp. 223–240.
18. Kanba, S., Kato, T., Terao, T., Yamada, K., Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012. Psychiatry Clin. Neurosci. 67:5 (2013), 285–300.
19. Kessing, L.V., Søndergård, L., Forman, J.L., Andersen, P.K., Lithium treatment and risk of dementia. Arch. Gen. Psychiatry 65:11 (2008), 1331–1335.
20. Kessing, L.V., Forman, J.L., Andersen, P.K., Does lithium protect against dementia?. Bipolar Disord. 12:1 (2010), 87–94.
21. Lewitzka, U., Bauer, M., What role does (should) lithium play in suicide treatment/prevention?. Psychiatr. Times, 31(12), 2014 (10-10).
22. Lewitzka, U., Severus, E., Bauer, R., Ritter, P., Müller-Oerlinghausen, B., Bauer, M., The suicide prevention effect of lithium: more than 20 years of evidence—a narrative review. Int. J. Bipolar Disord., 3(1), 2015, 1.
23. Malhi, G.S., Outhred, T., Therapeutic mechanisms of lithium in bipolar disorder: recent advances and current understanding. CNS Drugs 30:10 (2016), 931–949.
24. Malhi, G.S., Tanious, M., Das, P., Berk, M., The science and practice of lithium therapy. Aust. N.Z. J. Psychiatry 46:3 (2012), 192–211.
25. Malhi, G.S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P.B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust. N.Z. J. Psychiatry 49:12 (2015), 1087–1206.
26. Malhi, G.S., Byrow, Y., Boyce, P., Bassett, D., Fitzgerald, P.B., Hopwood, M., Lyndon, W., Mulder, R., Murray, G., Singh, A., Why the hype about subtype? Bipolar I, bipolar II–it's simply bipolar, through and through!. Aust. N.Z. J. Psychiatry 50:4 (2016), 303–306.
27. Malhi, G.S., Byrow, Y., Outhred, T., Fritz, K., Exclusion of overlapping symptoms in DSM-5 mixed features specifier: heuristic diagnostic and treatment implications. CNS Spectr., 2016, 1–8.
28. Malhi, G.S., Gershon, S., Outhred, T., Lithiumeter: version 2.0. Bipolar Disord. 18:8 (2016), 631–641.
29. Malhi, G.S., McAulay, C., Gershon, S., Gessler, D., Fritz, K., Das, P., Outhred, T., The lithium battery: assessing the neurocognitive profile of lithium in bipolar disorder. Bipolar Disord. 18:2 (2016), 102–115.
30. Malhi, G.S., Masson, M., Bellivier, F., The Science and Practice of Lithium Therapy. 2017, Springer International Publishing, Switzerland.
31. McKnight, R.F., Adida, M., Budge, K., Stockton, S., Goodwin, G.M., Geddes, J.R., Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379:9817 (2012), 721–728.
32. McKnight, R.F., Geddes, J.R., Goodwin, G.M., 2017. Short-and midterm side effects of lithium therapy. In: The Science and Practice of Lithium Therapy, Springer, pp. 249–264.
33. Mok, Y., Chan, H., Chee, K., Chua, T., Lim, B., Marziyana, A., Peh, L., Song, C., Tung, Y., Yap, P., Ministry of health clinical practice guidelines: bipolar disorder. Singap. Med. J. 52:12 (2011), 914–919.
34. Ng, F., Mammen, O.K., Wilting, I., Sachs, G.S., Ferrier, I.N., Cassidy, F., Beaulieu, S., Yatham, L.N., Berk, M., The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 11:6 (2009), 559–595.
35. NICE, 2014. Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. Clinical Guideline 185. National Institute for Health and Clinical Excellence, London.
36. Sutter-Dallay, A.-L., Brun, S., 2017. Lithium and pregnancy. In: The Science and Practice of Lithium Therapy, Springer, pp. 293–301.
37. Taylor, D., Paton, C., Kapur, S., The Maudsley Prescribing Guidelines in Psychiatry. 2015, John Wiley & Sons, Chichester, United Kingdom.
38. Yatham, L.N., Kennedy, S.H., Parikh, S.V., Schaffer, A., Beaulieu, S., Alda, M., O'Donovan, C., MacQueen, G., McIntyre, R.S., Sharma, V., Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 15:1 (2013), 1–44.